GlassScriptPhysician profile
John H Babson
NPI 1427016179
$869.27
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2020: $253 · 2021: $293 · 2022: $141 · 2023: $33.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $33.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $33.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $126.80 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $86.21 | 2019-2021 | |
| Glaxosmithkline, LLC. | $83.15 | 2020-2022 | |
| Abbvie INC. | $63.68 | 2021-2023 | Ubrelvy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.77 | 2019-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $39.42 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $36.90 | 2021 | |
| Mylan Specialty L.P. | $35.64 | 2019-2021 | |
| Novo Nordisk INC | $33.71 | 2020-2022 | |
| Inari Medical, INC. | $33.53 | 2022 | |
| Vanda Pharmaceuticals INC. | $31.86 | 2022 | |
| Pfizer INC. | $27.79 | 2019 | |
| Lilly USA, LLC | $26.65 | 2020-2021 | |
| Amgen INC. | $24.71 | 2022 | |
| Amarin Pharma, INC. | $20.89 | 2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Upsher-Smith Laboratories LLC | $18.33 | 2020 | |
| Janssen Pharmaceuticals, INC | $16.67 | 2019 | |
| Astellas Pharma US INC | $15.39 | 2021 | |
| Daiichi Sankyo INC. | $15.29 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.77 | 2021 | |
| Nestle Healthcare Nutrition INC. | $14.38 | 2020 | |
| Alkermes, INC. | $13.30 | 2022 | |
| Dexcom, INC. | $13.01 | 2021 | |
| Abbott Laboratories | $12.77 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $12.05 | 2020 | |
| Sanofi Pasteur INC. | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Babson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.